Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionKCXIX - Knights of Columbus U.S. All Cap Index Fund I Shares
Latest Disclosed Ownership624 shares
Latest Disclosed Value $ 17,553
KCXIX - Knights of Columbus U.S. All Cap Index Fund I Shares reports 7.77% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On June 25, 2026 - KCXIX - Knights of Columbus U.S. All Cap Index Fund I Shares filed a NPORT-P form disclosing ownership of 624 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $17,553 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 579 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 7.77% during the quarter. The current value of the position is $19,650 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-25 2026-04-30 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 624 45 7.77 18 21.43 0.0051
2026-03-27 2026-01-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 579 56 10.71 14 27.27 0.0046
2025-12-30 2025-10-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 523 20 3.98 11 10.00 0.0039
2025-09-29 2025-07-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 503 35 7.48 11 -9.09 0.0044
2025-06-26 2025-04-30 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 468 7 1.52 11 10.00 0.0055
2025-04-01 2025-01-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 461 94 25.61 10 25.00 0.0050
2024-12-30 2024-10-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 367 0 0.00 8 33.33 0.0043
2024-09-26 2024-07-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 367 49 15.41 6 50.00 0.0036
2024-06-28 2024-04-30 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 318 32 11.19 5 0.00 0.0033
2024-03-28 2024-01-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 286 36 14.40 4 33.33 0.0031
2023-12-28 2023-10-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 250 0 0.00 3 0.00 0.0030
2023-09-28 2023-07-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 250 61 32.28 3 0.00 0.0034
2023-06-29 2023-04-30 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 189 0 0.00 3 50.00 0.0035
2023-03-30 2023-01-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 189 22 13.17 3 0.00 0.0037
2022-12-29 2022-10-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 167 0 0.00 2 100.00 0.0036
2022-09-28 2022-07-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 167 30 21.90 2 0.00 0.0028
2022-06-28 2022-04-30 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 137 0 0.00 1 0.0017
2022-03-31 2022-01-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 137 53 63.10 1 0.0013
2021-12-28 2021-10-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 84 16 23.53 0 0.0012
2021-09-28 2021-07-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 68 12 21.43 0 0.0014
2021-06-28 2021-04-30 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 56 0 0.00 0 -100.00 0.0011
2021-03-31 2021-01-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 56 1 1.82 0 0.0010
2020-12-23 2020-10-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 55 0 0.00 0 0.0010
2020-09-29 2020-07-31 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 55 2 3.77 0 0.0015
2020-06-26 2020-04-30 NP CATALYST PHARMACEUTICALS INC EC US14888U1016 53 53 0 0.0019
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.